
|Articles|June 3, 2014
Segment 4 - Biomarkers in Bone Turnover and Immunoglobulin Expression
Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression.
Advertisement
Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression. Dr Kumar says the use of biomarkers can be very specific to a disease type. He analyzes the use of bone marrow and bone biomarkers for monitoring myeloma bone disease. He says there are both prognostic and predictive biomarkers which suit different purposes. There are also other emerging biomarkers that are being studied and explored.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
3
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
4
Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits
5








